Rudolf Jaenisch, Founding Member, Whitehead Institute, Professor of Biology, Massachusetts Institute of Technology - KEYNOTE
Douglas Melton, Investigator, Howard Hughes Medical Institute, Thomas Dudley Cabot Professor, Harvard University, Co-Director,Harvard's Stem Cell Institute - KEYNOTE
Karen Aboody, Associate Professor, Neurosciences, City of Hope
Patrick Bilbo, Vice President, Regulatory Affairs & Government Relations, Organogenesis
Louis Breton, Chief Executive Officer, Calimmune
Casey Case, Executive Vice President, Research, SanBio
Larry Couture, Senior Vice President, Center for Applied Technology Development, Beckman Research Institute of City of Hope
Kevin A. D'Amour, Vice President of Research & Chief Scientific Officer, ViaCyte
Nathan Dowden, Managing Director, The Frankel Group LLC
Matthew Durdy, Chief Business Officer, Cell Therapy Catapult
Michael Ginsberg, Senior Scientist, Angiocrine Bioscience
Philip Gregory, Chief Scientific Officer, Sangamo BioSciences
Philippe Henon, Chief Operating Officer & Chairman, CellProthera
Johan Hyllner, Chief Scientific Officer, Cellectis Stem Cell, Adjunct Professor, Linköping University
Hardy T S Kagimoto, President & CEO, Retina Institute Japan (RIKEN Venture)
Rusty Kelley, Director, Regenerative Medicine & Biology, Tengion
Jonathan Sackner-Bernstein, Vice President, Clinical Development & Regulatory Affairs, NeoStem
Kwang-Soo Kim, Professor and Director, Molecular Neurobiology Laboratory ,Harvard Medical School
Michael Laflamme, Associate Professor, Department of Pathology Center for Cardiovascular Biology, University of Washington
Jane Lebkowski, President & Chief Scientific Officer, Regenerative Patch Technologies
Ken Livak, Senior Scientific Fellow, Fluidigm Corporation
John (Shi-Jiang) Lu, Senior Director for Research, Advanced Cell Technology
Ramkumar Mandalam, President and Chief Executive Officer, Cellerant Therapeutics
Huseyin Mehmet, Lead, Target Identification and Validation, Respiratory & Immunology, Former Director of Apoptosis Research, Merck
Frank McKeon, Director of Quantitative Cell Biology, The Jackson Laboratory for Genomic
Toshio Miki, Assistant Professor, University of Southern California, Keck School of Medicine
Gordana Novakovic, Professor & Vice-Chair, Biomedical Engineering, Columbia University
Ornella Parolini, Director, Centro di Ricerca E. Menni, Italy, President, International Placenta Stem Cell Society
Marc Penn, Cardiologist & Director, Research, Summa Health System and Northeast Ohio Medical University, Founder and Chief Medical Officer, Juventas Therapeutics, Inc.
Robert A. Preti, President, Progenitor Cell Therapy
Mahendra Rao, Director, Center for Regenerative Medicine, NIH
Peter Rubin, Director, Adipocyte Biology Laboratory, University of Pittsburgh; Regenerative Medicine, McGowan Institute
Evan Snyder, Professor and Director, Program in Stem Cell & Regenerative Biology, Sanford-Burnham Medical Research Institute
Shay Soker, Professor of Regenerative Medicine, Wake Forest Institute, Regenerative Medicine Medical Center
Paul Stroemer, CTX Programme Manager, ReNeuron
Anthony Ting, Senior Director, Regenerative Medicine, Athersys
Alain Vertes, Sloan Fellow, London Business School
Yu-Chieh Wang, Research Associate, Center for Regenerative Medicine, Jeanne F. Loring's Lab, The Scripps Research Institute
...and more!
For an updated speaker list, click here.
Register before Feb 28th and save 20%!
Sign up 3 people for the price of 2! Use discount code rcdvb.
|
| <hr/> |
GTC's Upcoming Conferences
|
|
2nd Novel Cancer Therapeutics Summit
February 25-26, 2013, Las Vegas, NV
4th Cancer Targets & Therapeutics
February 25-26, 2013, Las Vegas, NV
2nd Oncology Partnering & Deal-Making
February 25-26, 2013, Las Vegas, NV
3rd Ubiquitin Research & Drug Development
February 25-26, 2013, Las Vegas, NV
5th Ocular Diseases & Drug Development
March 21-22, 2013, San Francisco, CA
10% discount by February 21st
Biomarker Summit 2013
March 20-22, 2013 San Francisco, CA
10% discount by February 20th
6th Oncology Biomarkers
March 20-22, 2013 San Francisco, CA
10% discount by February 20th
2nd Neurological Biomarkers
March 20-22, 2013 San Francisco, CA
10% discount by February 20th
2nd Inflammatory & Immunological Biomarkers
March 20-22, 2013 San Francisco, CA
10% discount by February 20th
3rd Cancer Immunotherapy & Immunomonitoring
(CITIM 2013)
April 22 - 25, 2013
Krakow, Poland, POL
Diabetes Summit 2013
April 29-30, 2013 Boston, MA
20% discount before February 28th!
6th Diabetes Drug Discovery & Development
April 29-30, 2013 Boston, MA
20% discount before February 28th!
3rd Diabetes Partnering & Deal-Making
April 29-30, 2013 Boston, MA
20% discount before February 28th!
Drug Discovery Summit 2013
May 8-10, 2013 Boston, MA
20% discount before March 8th!
7th Drug Design & Medicinal Chemistry
May 8-10, 2013 Boston, MA
20% discount before March 8th!
Orphan Drugs Research & Commercialization
May 8-10, 2013 Boston, MA
20% discount before March 8th!
3rd Epigenetics in Drug Discovery
May 8-10, 2013 Boston, MA
20% discount before March 8th!
6th Imaging in Drug Discovery
May 8-10, 2013 Boston, MA
20% discount before March 8th!
4th RNAi Research & Therapeutics
June 19-21, 2013 San Francisco, CA
20% discount before April 19th!
3rd Next Generation Sequencing
June 19-21, 2013 San Francisco, CA
20% discount before April 19th!
11th Vaccines Research & Development: All Things Considered
July 8-10, 2013 Boston, MA
20% discount before May 8th!
10th Anti-Infectives Partnering & Deal-Making
July 8-10, 2013 Boston, MA
20% discount before May 8th!
8th Protein Kinases in Drug Discovery
July 8-10, 2013 Boston, MA
20% discount before May 8th!
|
|
Комментарии